Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 1,688 | 775 | 765 | 880 | 1,031 |
| Operating Income | -1,688 | -775 | -765 | -880 | -1,031 |
| Interest Expense | 7 | 0 | 36 | 27 | 0 |
| Other Income | 936 | 1,015 | -981 | -441 | 1,466 |
| Pre-tax Income | -759 | 240 | -1,782 | -1,348 | 435 |
| Net Income Continuous | -759 | 240 | -1,782 | -1,348 | 435 |
| Net Income Discontinuous | -6,210 | -1,267 | N/A | N/A | N/A |
| Net Income | $-6,969 | $-1,027 | $-1,782 | $-1,348 | $435 |
| EPS Basic Total Ops | -0.80 | -0.20 | -1.20 | -0.80 | 0.40 |
| EPS Basic Continuous Ops | -0.08 | 0.04 | -1.31 | -0.99 | 0.33 |
| EPS Basic Discontinuous Ops | -0.69 | -0.19 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.80 | -0.20 | -1.20 | -0.80 | 0.00 |
| EPS Diluted Continuous Ops | -0.08 | 0.04 | -1.31 | -0.99 | 0.28 |
| EPS Diluted Discontinuous Ops | -0.69 | -0.19 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | -1.20 | -1.32 | 0.00 | 0.28 |
| EBITDA(a) | $-1,688 | $-576 | $-765 | $-879 | $-1,030 |